Viral hepatitis C is one of the most prevalent infectious diseases in the world and may cause serious hepatic diseases in the future. Hepatitis C-infected people account for approximately 2% to 3% of the world's population. The main causes of hepatitis C infection in developing countries are unsafe medical injection and contaminated blood and blood products; whereas in developed countries, it is mainly caused by injection, drug abuse, and high-risk sexual behavior. The focus of hepatitis C prevention and control should be placed on safer blood supply, safer health care and related unnecessary injection, reduction of injection drug use, and high-risk sexual behavior because effective vaccine and postexposure prophylaxis are not yet available.
Viral hepatitis C (hepatitis C) is one of the most frequent incidences of infectious diseases caused by hepatitis C virus (HCV) infection. Approximately 2% to 3% of the world' s population is infected by HCV. Hepatitis C infection is featured by liver damage, in which most of the people are generally susceptible but no effective vaccine and postexposure prevention exist thus far. HCV is often considered a "silent killer" because the patients have no symptoms or no specific symptoms after being infected, and many people are unaware of their own infection until the occurrence of cirrhosis or hepatocellular carcinoma [1, 2] . Moreover, the spontaneous clearance of patients with HCV is weak; therefore, approximately 70% of patients will suffer from chronic liver diseases. Developed countries rank the highest in end-stage liver disease, and hepatitis C-related death rate in the United States has increased significantly more than HIVrelated death rate [1] [2] [3] . In recent years, an epidemic outbreak of hepatitis C in many cities and aggregation epidemic in some rural areas have caused public attention and social panic [4] . The prevention and control of the disease depend on accurate and reliable epidemiological data, particularly the etiologic research on infection. This paper summarizes the risk factors of hepatitis C infection and provides an objective reference for the on-site epidemiological investigation, the modification of diagnostic criteria of viral hepatitis C, and the formulation of prevention and control measures.
Iatrogenic infection
Blood transf usion or blood products, unsafe medical treatment, dialysis and surgical operation, and other iatrogenic infections are the most common causes for the outbreak of hepatitis C across the world. In some countries and regions, the rate of incidence and infection of hepatitis C declines after relevant prevention and control measures are applied. In some less developed countries, the spread of hepatitis C is caused by lack of disposable syringes and health care facilities and by re-use of needles, syringes, and infusion bags, among others [5] . Before the HCV was discovered and biological tests emerged, hepatitis C infection caused by blood transfusion, blood products, and blood donation is immeasurable. After measures of blood and blood products screening were implemented, the rate of incidence and infection of hepatitis C reduced, even lower than the general population in some areas [6] . In Egypt, intravenous therapy of anti-schistosomiasis is the main reason for the epidemic of hepatitis C infection causing serious iatrogenic infection. After the drugs of oral treatment of schistosomiasis are used and the norms of safe injection are set, the incidence of hepatitis C gradually decreased [7] . Injection of glass syringes increases the risk of hepatitis C infection, whereas the reduction of the use of glass syringes and of disposable syringes can effectively prevent hepatitis C. Guadagnino et al. found that the injection of glass syringe is one of the risk factors (OR=3.2, 95%CI: 1.4 -7.3); the rate of hepatitis C infection decreases from 12.6% to 5.7% after one-time syringe was used widely and that of all age groups decreases as well [8] . A certain relationship exists between the hepatitis C infection rate and injection frequency. The higher the injection frequency, the higher the probability of infection. Zhang et al. conducted a case-control study and found that 3 to 10 times of injection a year is a risk factor (OR=5.147, 95%CI: 1.601-16.550) [9] . Goyet et al. also concluded that compared with HIV single infection, HIV and HCV coinfected older people (>50 years) (OR=5.4, 95%CI: 1.5-19.6) five times more than intramuscular injection, and the risk factors are intravenous injection, blood transfusion (OR=3.4, 95%CI: 1.5-7.6), operation (OR=2.6, 95%CI: 1.2-5.7), and colonoscopy (OR=2.4, 95%CI: 1.0-5.7) [10] . The incidence of dialysis is different in different areas; the incidence in developing countries is higher than that in developed countries. Su et al. found that the incidence in developing countries is five times that in developed countries [11] . Medical conditions may affect the incidence of disease; the incidence and prevalence of hepatitis C among dialysis patients have declined due to health prevention and isolation measures and gradual implementation of dialysis in most Western countries [12] .
Injection drug use
With the emergence of new drugs, drug users have changed the manner of drug abuse. Injection drug use is still one of the most effective modes of spread of HCV infection. In developed countries, injection drug use has gradually become the main factor of hepatitis C infection. Although the proportion of hepatitis C infection caused by injection drug use in developing countries is lower than that in developed countries, the incidence of hepatitis C is higher among injection drug users (IDU). Nelson et al. conducted a systematic review on IDU hepatitis C infection in 77 countries and found that IDU hepatitis C infection rate is over 80% in 12 countries, 60% to 80% in 25 countries, and 4 0% to 60 % in 2 4 countr ies. Approx imately 10 million IDUs worldwide are hepatitis C antibody-positive carriers; China, United States, and Russia are the three most infected countries, accounting for nearly half of the proportion [13] . Zhou et al. conducted a case-control study and found that hepatitis C infection is connected with the frequency of injection drug use (1/d) (OR=1.69, 95%CI: 1.12-2.55), injection drug time (≥5 years) (OR=2.26, 95%CI: 1.66-3.08), and shared syringe/needle (OR=2.63, 95%CI:
1.85-3.75) [14] . Amin et al. conducted a cross-sectional study on IDU population and found that female drug addicts (OR=5.0, 95%CI: 2.0-10.0), unmarried drug users (OR=2.9, 95%CI: 1.9-4.4), drug use of 10 years above (OR=2.7, 95%CI: 1.8-3.9), and high frequency of injection (>1 time / d) (OR=2.6, 95%CI: 1.6-4.2) are the risk factors for hepatitis C infection [15] . Kassaian [17] .
Heterosexual and homosexual sex
Some controversies exist that sexual behavior also causes hepatitis C, especially the sexual intercourse of fixed spouse/ sexual partner. Although the methods of spread are similar, the sexual spread of HCV is less efficient than that of hepatitis B virus and HIV virus, but the HCV-infected persons and the prevalence of sexual behavior compose a large number of viral repositories, which cannot be ignored. Compared with fixed spouse/sexual partner, multiple sexual partner, male homosexual sex actor, HCV-infected sexual partner, HCV and HIV co-infected sexual partner, and sexual partner of injection drug use increase the risk of hepatitis C infection. W hen the spouse/partner is in the acute phase of HCV infection, sexual spread may be more efficient; whether the gender difference between men and women affects hepatitis C infection is still unclear [18] . Terrault et al. conducted a follow-up survey on 500 hepatitis C antibody positive carriers and their 15 years' fixed heterosexual sexual partners and found that only 20 cases of them are hepatitis C antibody positive, of which 9 cases have the same genotype with their spouses; they also found that 190,000 times of sexual behavior can cause hepatitis C infection [19] . Wandeler et al. conducted a follow-up study and found that HCV incidence in IDU population with HIV infections decreases, but the HCV incidence in MSM population with HIV infection increases by 18 times. They also conducted a COX regression analysis and found that HCV incidence in MSM population is associated with interruption of condom use (HR=2.09, 95%CI: 1.33-3.29), syphilis infection (HR=2.11, 95%CI: 1.39-3.20), and HCV seroconversion [20] .
Mother-to-child transmission
Mother-to-child transmission of hepatitis C is uncommon; before 1992, iatrogenic infection may be the main way for infants to be infected with HCV [21] . W hen maternal serum HCV RNA is negative, the possibility of neonatal infection with HCV is very little; when maternal serum HCV RNA is positive, the possibility of neonatal infection with HCV will be increased from 4% to 7%. The neonatal infection is associated with perinatal infection, prolonged labor after the rupture of membranes (OR=9.3, 95%CI: 1.5-179.7), and intrauterine monitoring of embryo (e.g., amniocentesis) (OR= 6.7, 95%CI: 1.1-35.9) [21] . Fewer copy number of viral load (below 105) is less likely to increase infection; more copy number of viral load (below 105) is likely to increase infection (higher than 10 6 /mL), and concurrent HIV infection will even increase the risk of infection by threefold or fivefold [22] .
Summaries
Risk factors of hepatitis C infection vary from region to region in different countries. In developed countries, hepatitis C infection is mainly caused by injection drug use and high-risk sexual behavior, whereas in developing countries, the infection is mainly caused by unsafe medical injection and contaminated blood and blood products. Many factors may be related to hepatitis C infection, including demographic characteristics (age, sex, ethnicity, marital status, and occupation, etc.), personal behavior and religious beliefs (tattoos, punches, hairdressing, sharing of toothbrushes, sharing of razors, circumcision and rituals, etc.), health care and cosmetology (oral treatment, tattoo, eyebrow embroidery, plastic surgery, acupuncture, scraping, and cupping, etc.), and socioeconomic conditions (income, local medical and health conditions). In China's public health services, hepatitis C prevention and control work should focus on blood donation, blood transfusion, preoperative hepatitis C screening, safe injection of medical institutions and related clinics, reduction of injection drug use, and high-risk sexual behavior. The implementation of these measures also requires public health physicians, clinicians, and laboratory testing personnel to work together with other relevant third-party organizations to improve detection, monitoring, intervention, and treatment of hepatitis C.
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